Clovis Oncology
CLVS
$0.08120
Share price
0.00%
Change (1 day)
-95.08%
Change (1 year)
Categories
Number of shares outstanding for Clovis Oncology (CLVS)
Number of shares outstanding as of April 2024 : 144,625,000
According to Clovis Oncology's latest financial reports and stock price the company's current number of shares outstanding is 144,625,000. At the end of 2022 the company had 144,625,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Clovis Oncology from 2010 to 2022
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2022 | 0.14 B | 19.31% |
| 2021 | 0.12 B | 37.35% |
| 2020 | 88.25 M | 61.32% |
| 2019 | 54.7 M | 3.87% |
| 2018 | 52.66 M | 7.67% |
| 2017 | 48.91 M | 26.93% |
| 2016 | 38.53 M | 2.46% |
| 2015 | 37.61 M | 10.88% |
| 2014 | 33.92 M | 12.89% |
| 2013 | 30.04 M | 15.8% |
| 2012 | 25.94 M | 1913.03% |
| 2011 | 1.28 M | 0% |
| 2010 | 1.28 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 1,564.44% | 🇺🇸 USA |
 Pfizer PFE | 5,647,000,000 | 3,804.58% | 🇺🇸 USA |
 AbbVie ABBV | 1,765,940,733 | 1,121.05% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | 556.44% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 2,042.09% | 🇬🇧 UK |
 BioMarin Pharmaceutical BMRN | 188,219,000 | 30.14% | 🇺🇸 USA |